Rainmed Medical Limited (02297.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

Market Cap

HKD 248.05M

MomentumView details →

1D Return

+1.59%

YTD Return

−28.89%

RSI (14)

40.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.6x

Market Cap

HKD 248.05M

RSI (14)

40.8

MomentumView details →

1D Return

+1.59%

YTD Return

−28.89%

ProfitabilityView details →

Gross Margin

55.77%

Net Margin

−323.02%

EBITDA Margin

−244.37%

ROE (TTM)

−53.30%

ROA (TTM)

−34.92%

Asset Turnover

0.11x

GrowthView details →

Revenue YoY

−62.38%

EPS YoY

+90.26%

FCF YoY

+43.09%

Revenue CAGR 3Y

−38.79%

EPS CAGR 3Y

+40.30%

EBITDA YoY

+89.90%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

1.13x

Quick Ratio

1.07x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

59.00M

Net Income (TTM)

−190.58M

Op. CF (TTM)

−166.24M

Latest newsMore news →

Runmed Medical-B (02297.HK) announced its interim results for the six months ended June 2026, with revenue of RMB 14.672 million, up 41% year-on-year, and a narrowed net loss of RMB 21.989 million from RMB 32.169 million in the same period last year.4d ago

Similar companies

Profound Medical Corp.PROF RxSight, Inc.RXST Standard BioTools Inc.LAB Anika Therapeutics, Inc.ANIK Broncus Holding Corporation02216.HK TriSalus Life Sciences, Inc.TLSI Find similar companies →

Latest newsMore news →

Runmed Medical-B (02297.HK) announced its interim results for the six months ended June 2026, with revenue of RMB 14.672 million, up 41% year-on-year, and a narrowed net loss of RMB 21.989 million from RMB 32.169 million in the same period last year.4d ago